NCT07252440
- Conditions
- AD, Alzheimer Disease, Brain Diseases, +8 more
- Locations
-
- Daping Hospital. Chongqing, Chongqing Municipality, China
Clinical trial condition
AD
Explore clinical trials studying AD. Study availability and eligibility vary by location and protocol.
12 public trials
3 recruiting studies
AD trial results
NCT07693738
- Conditions
- AD
- Locations
-
- Huashan Hospital, Fudan University Shanghai, China
NCT06335836
- Conditions
- AD, Alzheimer Disease, Behavior, +16 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, China, Jiangsu, China
Not yet recruiting
Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET
NCT07100470
- Conditions
- AD, FTD, Healthy Controls
- Locations
-
Not specified
Enrolling by invitation
Home-Based Closed-Loop Auditory Stimulation to Enhance Slow-Wave Activity in MCI Due to Alzheimer's Disease: A Proof-of-Concept Study
NCT07672977
- Conditions
- AD, AD-MCI, Alzheimer s Disease, +6 more
- Locations
-
- Bit&Brain Technologies SL Zaragoza, Spain
Enrolling by invitation
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
NCT06245031
- Conditions
- AD, Alzheimer Disease, Brain Diseases, +25 more
- Locations
-
- Barrow Neurological Institute Phoenix, Arizona, United States
- CCT Research - Foothills Research Center Phoenix, Arizona, United States
- Banner Sun Health Research Institute Sun City, Arizona, United States
- Advanced Research Center, Inc Anaheim, California, United States
Active, not recruiting
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
NCT07011706
- Conditions
- AD, Atopic, Atopic Dermatitis, +12 more
- Locations
-
- Aclaris Clinical Site Phoenix, Arizona, United States
- Aclaris Clinical Site Tucson, Arizona, United States
- Aclaris Study Site Bryant, Arkansas, United States
- Aclaris Clinical Site Beverly Hills, California, United States
Completed
A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection
NCT06593626
- Conditions
- AD, MCI
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
Completed
Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
NCT02380573
- Conditions
- AD, Aging, Alzheimer Disease, +13 more
- Locations
-
- Research Imaging Institute, The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
NCT03932916
- Conditions
- AD
- Locations
-
- Shanghai mental health center Shanghai, Shanghai Municipality, China